Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects

4 Nov 2005

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Myeloid Leukemia Treatments
Share to Eosinophilic Disorders and Syndromes
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 16271512
DOI: 10.1016/j.molmed.2005.10.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospectsPMID 16271512Read ↗

<i>JAK2</i>Mutations in Myeloproliferative DisordersSemantic proximity Read ↗

[Pathogenetic role of JAK2 gene mutation in chronic myeloproliferative disorders].Semantic proximity Read ↗

[JAK2 mutation in myeloproliferative disorders].Semantic proximity Read ↗

Update on the impact of the JAK2 mutation on signalling pathways in myeloproliferative disorders.Semantic proximity Read ↗

[Myeloproliferative diseases caused by Jak2 gene mutation].Semantic proximity Read ↗

BCR/ABL-negative chronic myeloproliferative disorders: JAK2 mutation and beyond.Semantic proximity Read ↗

JAK2: implications for diagnosis and classification of myeloproliferative disorders.Semantic proximity Read ↗

The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasmsSemantic proximity Read ↗

JAK2 V617F: a single mutation in the myeloproliferative group of disorders.Semantic proximity Read ↗

[JAK2 gene mutation in chronic myeloproliferative disorders].Semantic proximity Read ↗

[JAK2 mutation can be used in diagnosis of myeloproliferative diseases].Semantic proximity Read ↗

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.